Allianz Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-8,200
| Closed | -$664K | – | 1714 |
|
|
2023
Q2 | $664K | Hold |
8,200
| – | – | ﹤0.01% | 1251 |
|
|
2023
Q1 | $652K | Buy |
+8,200
| New | +$652K | ﹤0.01% | 1369 |
|
|
2022
Q3 | – | Sell |
-179,552
| Closed | -$10M | – | 1594 |
|
|
2022
Q2 | $10M | Buy |
179,552
+47,062
| +36% | +$2.62M | 0.01% | 866 |
|
|
2022
Q1 | $7.36M | Sell |
132,490
-1,556
| -1% | -$86.4K | 0.01% | 990 |
|
|
2021
Q4 | $7.51M | Sell |
134,046
-18,638
| -12% | -$1.04M | 0.01% | 1006 |
|
|
2021
Q3 | $7.33M | Buy |
152,684
+113,794
| +293% | +$5.46M | 0.01% | 990 |
|
|
2021
Q2 | $1.63M | Sell |
38,890
-3,504
| -8% | -$147K | ﹤0.01% | 1352 |
|
|
2021
Q1 | $1.43M | Buy |
42,394
+2,348
| +6% | +$79.1K | ﹤0.01% | 1359 |
|
|
2020
Q4 | $1.4M | Buy |
40,046
+8,330
| +26% | +$291K | ﹤0.01% | 1385 |
|
|
2020
Q3 | $1.1M | Buy |
31,716
+742
| +2% | +$25.8K | ﹤0.01% | 1382 |
|
|
2020
Q2 | $1.01M | Buy |
30,974
+11,666
| +60% | +$382K | ﹤0.01% | 1418 |
|
|
2020
Q1 | $581K | Buy |
19,308
+3,442
| +22% | +$104K | ﹤0.01% | 1594 |
|
|
2019
Q4 | $459K | Buy |
15,866
+2,852
| +22% | +$82.5K | ﹤0.01% | 1941 |
|
|
2019
Q3 | $336K | Buy |
13,014
+1,000
| +8% | +$25.8K | ﹤0.01% | 1990 |
|
|
2019
Q2 | $306K | Buy |
12,014
+884
| +8% | +$22.5K | ﹤0.01% | 2049 |
|
|
2019
Q1 | $291K | Buy |
11,130
+1,470
| +15% | +$38.4K | ﹤0.01% | 2075 |
|
|
2018
Q4 | $223K | Buy |
+9,660
| New | +$223K | ﹤0.01% | 2026 |
|
|
2018
Q1 | – | Sell |
-7,734
| Closed | -$208K | – | 2159 |
|
|
2017
Q4 | $208K | Buy |
+7,734
| New | +$208K | ﹤0.01% | 2063 |
|